| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1068964992 |
| P356 | DOI | 10.2119/2007-00017.MAS |
| P932 | PMC publication ID | 1906687 |
| P698 | PubMed publication ID | 17622313 |
| P2093 | author name string | Robert A Fisher | |
| Daniel G Maluf | |||
| Kellie J Archer | |||
| Kenneth Yanek | |||
| Valeria R Mas | |||
| Anne L King | |||
| Eric M Gibney | |||
| Adrian Cotterell | |||
| Luciana A Mas | |||
| Marc Posner | |||
| P2860 | cites work | Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes | Q24675073 |
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Enhanced granulysin mRNA expression in urinary sediment in early and delayed acute renal allograft rejection | Q28269113 | ||
| Role of transforming growth factor-beta1 in the progression of chronic allograft nephropathy | Q34259063 | ||
| Chronic allograft nephropathy: current concepts and future directions | Q34501818 | ||
| Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation | Q35961030 | ||
| TACE-dependent EGF receptor activation in angiotensin-II-induced kidney disease | Q36442731 | ||
| Therapeutic targets in the treatment of allograft fibrosis | Q36447581 | ||
| Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway | Q36598311 | ||
| Urinary cytotoxic molecular markers for a noninvasive diagnosis in acute renal transplant rejection. | Q43501630 | ||
| Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine | Q43556887 | ||
| Comparing methods for monitoring serum creatinine to predict late renal allograft failure | Q43783219 | ||
| Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells | Q43818212 | ||
| Molecular and structural consequences of early renal allograft injury | Q43889575 | ||
| Expression of urokinase plasminogen activator and its receptor during acute renal allograft rejection | Q44609813 | ||
| The natural history of chronic allograft nephropathy | Q44688416 | ||
| Predicting the grade of Banff 97 classification of chronic allograft nephropathy based on examination of graft dysfunction (a preliminary report). | Q44871076 | ||
| Establishing the molecular pathways involved in chronic allograft nephropathy for testing new noninvasive diagnostic markers | Q44927347 | ||
| Epidermal growth factor receptor expression in human renal allograft biopsies: an immunohistochemical study. | Q45069263 | ||
| The UNOS Scientific Renal Transplant Registry. | Q46098850 | ||
| Long-term deterioration of kidney allograft function | Q46485576 | ||
| Conversion from calcineurin inhibitors to sirolimus in chronic allograft dysfunction: changes in glomerular haemodynamics and proteinuria | Q46798712 | ||
| Assessment by flow cytometry of intracellular cytokine production in the peripheral blood cells of renal transplant recipients | Q47249151 | ||
| Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine | Q47588349 | ||
| The change in allograft function among long-term kidney transplant recipients | Q47895894 | ||
| Early prognosis of the development of renal chronic allograft rejection by gene expression profiling of human protocol biopsies | Q47949686 | ||
| Early post-transplant urinary IP-10 expression after kidney transplantation is predictive of short- and long-term graft function | Q50113825 | ||
| Increased immunoreactivity of transforming growth factor-beta in human kidney transplants. | Q53737240 | ||
| Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. | Q53924174 | ||
| TGF-beta1 mRNA upregulation influences chronic renal allograft dysfunction. | Q54608975 | ||
| The Banff 97 working classification of renal allograft pathology | Q59314413 | ||
| Cytokine mRNA expression in chronically rejected human renal allografts | Q61848548 | ||
| Intragraft TGF-beta 1 mRNA: a correlate of interstitial fibrosis and chronic allograft nephropathy | Q71324547 | ||
| Chronic renal allograft rejection: immunologic and nonimmunologic risk factors | Q71568719 | ||
| Altered expression of transforming growth factor-beta S in chronic renal rejection | Q71612634 | ||
| Cytokine and cytotoxic molecule gene expression determined in peripheral blood mononuclear cells in the diagnosis of acute renal rejection | Q73111932 | ||
| Intragraft expression of transforming growth factor-beta 1 by a novel quantitative reverse transcription polymerase chain reaction ELISA in long lasting kidney recipients | Q74265370 | ||
| Impact of delayed graft function and acute rejection on kidney graft survival | Q74397282 | ||
| Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts | Q77349284 | ||
| Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group | Q77781312 | ||
| Intragraft messenger RNA expression of angiotensinogen: relationship with transforming growth factor beta-1 and chronic allograft nephropathy in kidney transplant patients | Q78293948 | ||
| The ratio of interferon-gamma and interleukin-10 producing donor-specific cells as an in vitro monitoring tool for renal transplant patients | Q79150758 | ||
| Assessing long-term nephron loss: is it time to kick the CAN grading system? | Q80845712 | ||
| Differential expression of profibrotic and growth factors in chronic allograft nephropathy | Q82547242 | ||
| P433 | issue | 5-6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 315-324 | |
| P577 | publication date | 2007-05-01 | |
| P1433 | published in | Molecular Medicine | Q6895961 |
| P1476 | title | Evaluation of gene panel mRNAs in urine samples of kidney transplant recipients as a non-invasive tool of graft function | |
| P478 | volume | 13 |
| Q28552810 | A New Data Analysis System to Quantify Associations between Biochemical Parameters of Chronic Kidney Disease-Mineral Bone Disease |
| Q42724173 | A new clinical prediction tool for 5-year kidney transplant outcome |
| Q40638279 | A nonparametric fiducial interval for the Youden index in multi-state diagnostic settings |
| Q42849659 | Analysis of urinary gene expression of epithelial-mesenchymal transition markers in kidney transplant recipients. |
| Q38187177 | Biomarkers and possible mechanisms of operational tolerance in kidney transplant patients |
| Q50019794 | Human expression patterns: qualitative and quantitative analysis of thrombospondin-1 under physiological and pathological conditions |
| Q35049801 | Identifying biomarkers as diagnostic tools in kidney transplantation |
| Q37813414 | Immune monitoring and biomarkers to predict chronic allograft dysfunction |
| Q37591422 | Kidney transplantation: analysis of the expression and T cell-mediated activation of latent TGF-β. |
| Q38089948 | Molecular monitoring for rejection and graft outcome in kidney transplantation |
| Q37724869 | Molecular pathways involved in loss of graft function in kidney transplant recipients. |
| Q28679298 | Multicenter evaluation of a standardized protocol for noninvasive gene expression profiling |
| Q36677509 | Noninvasive prediction of organ graft rejection and outcome using gene expression patterns |
| Q28080994 | Reconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomes |
| Q46132415 | Relation of urinary gene expression of epithelial-mesenchymal transition markers with initial events and 1-year kidney graft function |
| Q58614731 | The role of CD47 in pathogenesis and treatment of renal ischemia reperfusion injury |
| Q30411597 | The urine microRNA profile may help monitor post-transplant renal graft function |
Search more.